T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANDV
1051
DELISTED
Andeavor
ANDV
| $25.5M | 0.01% |
342,323
-2,700
| -0.8% | -$190K |
|
1052
KLA
KLAC
$276B
| $25.3M | 0.01% |
3,602,050
+206,000
| +6% | +$1.52M |
|
|
HMIN
1053
DELISTED
HOMEINNS HOTEL GROUP SPONSORED ADR
HMIN
| $25.3M | 0.01% |
842,948
+141,057
| +20% | +$4.18M |
|
1054
Lincoln National
LNC
$8.61B
| $25.3M | 0.01% |
437,875
-2,900
| -0.7% | -$158K |
|
|
UBNK
1055
DELISTED
United Financial Bancorp, Inc.
UBNK
| $25M | 0.01% |
1,740,560
+602,594
| +53% | +$8.34M |
|
|
CALA
1056
DELISTED
Calithera Biosciences, Inc
CALA
| $24.9M | 0.01% |
+63,443
| New | +$16.6M |
|
|
BBBY
1057
DELISTED
Bed Bath & Beyond Inc
BBBY
| $24.9M | 0.01% |
326,618
-5,910
| -2% | -$413K |
|
|
WIRE
1058
DELISTED
Encore Wire Corp
WIRE
| $24.5M | 0.01% |
655,637
-2,900
| -0.4% | -$108K |
|
1059
Open Text
OTEX
$5.93B
| $24.5M | 0.01% |
838,330
+38,748
| +5% | +$1.1M |
|
1060
Main Street Capital
MAIN
$5.54B
| $24.3M | 0.01% |
831,859
+27,900
| +3% | +$861K |
|
|
CSBK
1061
DELISTED
Clifton Bancorp Inc.
CSBK
| $24M | 0.01% |
1,768,372
+1,542,419
| +683% | +$20M |
|
|
PPS
1062
DELISTED
Post Properties
PPS
| $24M | 0.01% |
407,788
-2,790
| -0.7% | -$157K |
|
|
LDR
1063
DELISTED
Landauer Inc
LDR
| $23.8M | 0.01% |
698,070
-3,600
| -0.5% | -$123K |
|
1064
MGIC Investment
MTG
$6.33B
| $23.8M | 0.01% |
2,550,221
+59,181
| +2% | +$520K |
|
|
NUAN
1065
DELISTED
Nuance Communications, Inc.
NUAN
| $23.8M | 0.01% |
1,922,745
-1,781
| -0.1% | -$22.9K |
|
|
KTWO
1066
DELISTED
K2M Group Holdings, Inc
KTWO
| $23.7M | 0.01% |
1,134,220
+13,800
| +1% | +$239K |
|
1067
Snap-on
SNA
$20.9B
| $23.6M | 0.01% |
172,701
+6,510
| +4% | +$853K |
|
1068
F5
FFIV
$23.8B
| $23.5M | 0.01% |
180,015
-400
| -0.2% | -$49.9K |
|
1069
Insteel Industries
IIIN
$634M
| $23.2M | ﹤0.01% |
984,900
+237
| +0% | +$5.29K |
|
1070
Principal Financial Group
PFG
$24.6B
| $23.2M | ﹤0.01% |
447,060
-800
| -0.2% | -$41.5K |
|
|
KLXI
1071
DELISTED
KLX Inc.
KLXI
| $23.1M | ﹤0.01% |
+665,525
| New | +$23.4M |
|
|
IMDZ
1072
DELISTED
Immune Design Corp.
IMDZ
| $23.1M | ﹤0.01% |
749,141
+8,900
| +1% | +$247K |
|
1073
Robert Half
RHI
$4.42B
| $23.1M | ﹤0.01% |
394,953
+22,800
| +6% | +$1.24M |
|
|
NEWP
1074
DELISTED
NEWPORT CORP
NEWP
| $23M | ﹤0.01% |
1,203,890
-10,300
| -0.8% | -$186K |
|
1075
MACOM Technology Solutions
MTSI
$24.1B
| $23M | ﹤0.01% |
733,770
-157,360
| -18% | -$3.9M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.